New Key Statistics Module, Z-Score and F-Score
NAS:VRTX Key Ratios
Market Cap $ M | 107,975.25 |
Enterprise Value $ M | 97,565.35 |
P/E(ttm) | 30.09 |
PE Ratio without NRI | 26.29 |
Forward PE Ratio | 25.70 |
Price/Book | 6.13 |
Price/Sales | 11.03 |
Price/Free Cash Flow | 33.21 |
Price/Owner Earnings | 38.48 |
Payout Ratio % | -- |
Revenue (TTM) $ M | 9,869.00 |
EPS (TTM) $ | 13.89 |
Beneish M-Score | -2.04 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 41.40 |
y-y EBITDA Growth Rate % | 3.30 |
EV-to-EBIT | 22.05 |
EV-to-EBITDA | 21.19 |
PEG | 0.64 |
Shares Outstanding M | 258.31 |
Net Margin (%) | 36.68 |
Operating Margin % | 43.65 |
Pre-tax Margin (%) | 44.38 |
Quick Ratio | 3.78 |
Current Ratio | 3.99 |
ROA % (ttm) | 17.76 |
ROE % (ttm) | 23.23 |
ROIC % (ttm) | 50.94 |
Dividend Yield % | -- |
Altman Z-Score | 14.84 |
Piotroski F-Score | 3.00 |
Positive ROA | Y |
Positive CFROA | Y |
Higher ROA y-y | N |
Cash flow > Earnings | N |
Lower Leverage y-y | Y |
Higher Current Ratio y-y | N |
Less Shares Outstanding y-y | N |
Gross Margin Increase y-y | N |
Higher Asset Turnover y-y | N |
VRTX Number of Guru Trades
VRTX Volume of Guru Trades
Gurus Latest Trades with NAS:VRTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:VRTX is held by these investors
Total 6
Vertex Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:VRTX
Total 0- 1